Personalized Treatment Selection

Oncogenomic testing helps match patients with targeted therapies and immunotherapies that are more likely to be effective based on their tumor's genetic profile.

Identification of Cancer-Driving Mutations

The test identifies key genetic alterations such as:

• Gene amplifications
• Gene deletions
• Gene fusions
• Other cancer-associated mutations

Understanding these changes helps guide treatment at the molecular level.

Liquid Biopsy & Advanced Diagnostics

Using circulating tumor DNA (ctDNA), oncogenomics enables minimally invasive blood-based testing that can help:

• Detect cancer-related genetic changes
• Monitor treatment effectiveness
• Track disease progression
• Identify treatment resistance

Prognostic Insights

Genomic analysis provides valuable information about:

• Disease progression
• Treatment response
• Risk of recurrence
• Overall clinical outlook